Addus HomeCare (NASDAQ:ADUS) EVP Sells $18,648.72 in Stock

Addus HomeCare Corporation (NASDAQ:ADUS) EVP Cliff Donald Blessing sold 177 shares of the stock in a transaction dated Wednesday, February 25th. The stock was sold at an average price of $105.36, for a total transaction of $18,648.72. Following the completion of the sale, the executive vice president directly owned 12,361 shares in the company, valued at approximately $1,302,354.96. The trade was a 1.41% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

Cliff Donald Blessing also recently made the following trade(s):

• On Tuesday, February 24th, Cliff Donald Blessing sold 350 shares of Addus HomeCare stock. The shares were sold at an average price of $107.14, for a total transaction of $37,499.00.

Addus HomeCare Price Performance

Addus HomeCare stock traded down $3.58 during midday trading on Thursday, reaching $104.02. 269,378 shares of the stock were exchanged, compared to its average volume of 239,147. Addus HomeCare Corporation has a 52 week low of $88.96 and a 52 week high of $124.43. The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.66 and a current ratio of 1.80. The firm has a market cap of $1.92 billion, a PE ratio of 19.97, a PEG ratio of 1.26 and a beta of 0.91. The company’s fifty day moving average is $109.57 and its 200-day moving average is $113.08.

More Addus HomeCare News

Here are the key news stories impacting Addus HomeCare this week:

• Positive Sentiment: Q4 earnings/earnings call emphasized continued revenue growth, margin-leverage opportunities and an M&A-driven growth strategy for 2026 — supports longer‑term earnings upside. Addus HomeCare Earnings Call Highlights Growth And Scale
• Positive Sentiment: Stephens trimmed its price target from $140 to $135 but kept an “overweight” rating — the new target implies meaningful upside from current levels, indicating analyst confidence in the company’s outlook despite the cut. Stephens price target note
• Neutral Sentiment: Addus will participate in the Raymond James Institutional Investors Conference (investor visibility event; typically neutral but can aid liquidity/coverage). Conference participation
• Neutral Sentiment: Some published short‑interest data in the feed shows zero shares (data glitch/inconsistent reporting across sources) — treat those specific zero figures with caution. MarketBeat ADUS page
• Negative Sentiment: Significant insider selling over Feb. 24–25: CEO R. Dirk Allison sold two blocks (4,988 and 2,364 shares) and multiple senior EVPs sold smaller blocks across the two days — coordinated insider sales can pressure sentiment even if individual sales are routine and pre‑planned. See CEO filing. CEO insider-sale SEC filing
• Negative Sentiment: Short interest rose earlier in February (as of Feb. 13 there were ~1.15M shares short, ~6.5% of shares outstanding and ~4.6 days‑to‑cover) — elevated short activity can amplify downward price moves. Short interest data

Analyst Upgrades and Downgrades

ADUS has been the subject of several research analyst reports. KeyCorp reissued an “overweight” rating on shares of Addus HomeCare in a research note on Wednesday. TD Cowen reaffirmed a “buy” rating on shares of Addus HomeCare in a report on Wednesday, November 5th. BMO Capital Markets started coverage on Addus HomeCare in a research report on Thursday, November 13th. They set a “market perform” rating and a $120.00 price target for the company. Weiss Ratings restated a “hold (c+)” rating on shares of Addus HomeCare in a research report on Wednesday, January 21st. Finally, Barclays lowered their target price on shares of Addus HomeCare from $117.00 to $112.00 and set an “underweight” rating on the stock in a research note on Tuesday. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $134.33.

Institutional Trading of Addus HomeCare

A number of hedge funds have recently bought and sold shares of ADUS. TimesSquare Capital Management LLC grew its position in Addus HomeCare by 6.2% during the third quarter. TimesSquare Capital Management LLC now owns 418,348 shares of the company’s stock valued at $49,361,000 after acquiring an additional 24,301 shares during the last quarter. Russell Investments Group Ltd. boosted its stake in shares of Addus HomeCare by 10.1% in the 2nd quarter. Russell Investments Group Ltd. now owns 55,900 shares of the company’s stock valued at $6,439,000 after purchasing an additional 5,110 shares in the last quarter. Public Sector Pension Investment Board grew its holdings in shares of Addus HomeCare by 14.4% during the 3rd quarter. Public Sector Pension Investment Board now owns 70,827 shares of the company’s stock valued at $8,357,000 after purchasing an additional 8,893 shares during the last quarter. Creative Planning raised its position in Addus HomeCare by 150.9% in the 2nd quarter. Creative Planning now owns 7,024 shares of the company’s stock worth $809,000 after purchasing an additional 4,224 shares during the period. Finally, Tributary Capital Management LLC raised its position in Addus HomeCare by 114.1% in the 3rd quarter. Tributary Capital Management LLC now owns 398,122 shares of the company’s stock worth $46,974,000 after purchasing an additional 212,192 shares during the period. Institutional investors own 95.35% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.